The protective efficacy of Celgene's candidate compounds CC-11050 and CC-5048 against Ebola virus in guinea pigs

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/11 → 8/30/12

Funding

  • Celgene Corporation: $64,738.00